NatiVita

en
  • Русский
  • English

Press releases

9.07.2018
NatiVita became a partner of Ride4Women charity bike ride

On Sunday, July 8th, NatiVita team took part in Ride4Women charity bike ride, which goal was to attract attention to women’s health problems and inform as many people as possible that cancer could be prevented and cured.

More
4.07.2018
Ride4women: faster than cancer

This Sunday, on July 8th Ride4Women charity bike ride dedicated to treatment of oncological diseases will be held supported by NatiVita.

More
28.05.2018
ProBiology: conference for young talents held in Vitebsk

On May 19th scientific and educational conference “ProBiology: molecules of life” was held in Vitebsk. More than 120 high school pupils and first-year students from all districts of Vitebsk region took part in the conference.

More
15.05.2018
NatiVita signed cooperation agreement in Japan

NatiVita and Japan company Chukan Butsu signed an engagement agreement at Belarusian and Japan Economic Forum on May 11th in Osaka (Japan).

More
13.05.2018
TalenaViта is spinning up

On May 19th we met with young scientists at scientific and educational conference “ProBiology: molecules of life” in Vitebsk.

More
10.05.2018
NatiVita registered GLACETAT drug for multiple sclerosis treatment

NatiVita has been granted with a product license for generic drug Glatiramer acetate brand named GLACETAT.

More
20.04.2018
New markets – new opportunities

As a member of the Belarusian delegation, NatiVita took part in the largest international pharmaceutical forum CPhI Japan, which was held on April 18-20 in Tokyo. Within the framework of the forum, representatives of NatiVita conducted negotiations with leading Japanese pharmaceutical companies and medical organizations in Tokyo and Osaka.

More